Search research articles
Contact Us
Filters
Showing results (391-400 of 459) with videos related to
Page
of 46
Sort By:
Leukemia & Lymphoma
|
December 27, 2024
Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS
Nandini Ramachandra, Charan Thej Reddy Vegivinti, Srabani Sahu, et al.
Blood
|
February 7, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study
Ioannis Mantzaris, Mendel Goldfinger, Matan Uriel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, et al.
Elife
|
March 28, 2023
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
Blood
|
June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Laura Barreyro, Britta Will, Boris Bartholdy, et al.
Blood
|
February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling
Tushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis
Christoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Journal of Hematology & Oncology
|
January 5, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Ahmed Abbasi, Stephen Peeke, Nishi Shah, et al.
Cancer Cell
|
March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
Koki Ueda, Rajni Kumari, Emily Schwenger, et al.
Leukemia & Lymphoma
|
July 11, 2019
Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regions
Timothy G Bowler, Kith Pradhan, Yu Kong, et al.
Page
of 46
Search research articles
Search
Showing results (391-400 of 459) with videos related to
Sort By:
Page
of 46
Leukemia & Lymphoma
|
December 27, 2024
Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS
Nandini Ramachandra, Charan Thej Reddy Vegivinti, Srabani Sahu, et al.
Blood
|
February 7, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study
Ioannis Mantzaris, Mendel Goldfinger, Matan Uriel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, et al.
Elife
|
March 28, 2023
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
Blood
|
June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Laura Barreyro, Britta Will, Boris Bartholdy, et al.
Blood
|
February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling
Tushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis
Christoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Journal of Hematology & Oncology
|
January 5, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Ahmed Abbasi, Stephen Peeke, Nishi Shah, et al.
Cancer Cell
|
March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
Koki Ueda, Rajni Kumari, Emily Schwenger, et al.
Leukemia & Lymphoma
|
July 11, 2019
Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regions
Timothy G Bowler, Kith Pradhan, Yu Kong, et al.
Page
of 46